AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17214382 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetition priming with dynamic chimeras
Number of subjects: 0
Study 17214382 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetition priming with static chimeras
Number of subjects: 0
Study 17214382 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetition priming with half-faces
Number of subjects: 0
Study 17214382 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetition priming with chimeras (restricted to recognized faces)
Number of subjects: 0
Study 12751846 — intervention group
Group type: EXPERIMENTAL
Intervention: Autism group
Number of subjects: 0
Study 12751846 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-exposed to labelled individual tones
Number of subjects: 0
Study 12751846 — intervention group
Group type: COMPARATOR
Intervention: Children with autism
Number of subjects: 0
Study 11369670 — intervention group
Group type: EXPERIMENTAL
Intervention: Propionic acid at 59.15 p.p.m.
Number of subjects: 24
Study 11369670 — intervention group
Group type: EXPERIMENTAL
Intervention: Propionic acid at 8.22 p.p.m.
Number of subjects: 24
Study 11369670 — intervention group
Group type: EXPERIMENTAL
Intervention: Propionic acid at 1.14 p.p.m.
Number of subjects: 24
Study 11369670 — intervention group
Group type: COMPARATOR
Intervention: Clean air (control)
Number of subjects: 24
Study 8994938 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive performance measured by Mini Mental State Examination, Benton Visual Retention Test, and Isaacs Set Test at baseline screening.
Number of subjects: 2726
Study 8427728 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life questionnaire (four different types)
Number of subjects: 140
Study 8427728 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life questionnaire (most reliable type from first study)
Number of subjects: 140
Study 2888302 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol, 50 mg
Number of subjects: 12
Study 2888302 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol, 50 mg
Number of subjects: 12
Study 2888302 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol, 25 mg
Number of subjects: 12
Study 2888302 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 29502805 — intervention group
Group type: EXPERIMENTAL
Intervention: HD201
Number of subjects: 73
Study 29502805 — intervention group
Group type: COMPARATOR
Intervention: EU‐trastuzumab
Number of subjects: 73
Study 28681717 — intervention group
Group type: COMPARATOR
Intervention: Guided self-help
Number of subjects: 475
Study 28681717 — intervention group
Group type: COMPARATOR
Intervention: Supported cCBT
Number of subjects: 475
Study 28681717 — intervention group
Group type: COMPARATOR
Intervention: Guided self-help and supported cCBT
Number of subjects: 475
Study 28681717 — intervention group
Group type: COMPARATOR
Intervention: Qualitative interviews
Number of subjects: 475
Study 26407689 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion
Number of subjects: 40
Study 26407689 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-obese patients)
Number of subjects: 40
Study 24176459 — intervention group
Group type: EXPERIMENTAL
Intervention: CTAS 5 patients admitted to hospital
Number of subjects: 37416
Study 24176459 — intervention group
Group type: EXPERIMENTAL
Intervention: Age over 65
Number of subjects: 37416
Study 24176459 — intervention group
Group type: EXPERIMENTAL
Intervention: Arrival by ambulance
Number of subjects: 37416
Study 21955733 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium 18 μg daily
Number of subjects: 5993
Study 21955733 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 5993
Study 18196610 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS text messaging reminder
Number of subjects: 1848
Study 18196610 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone reminder
Number of subjects: 1848
Study 18196610 — intervention group
Group type: COMPARATOR
Intervention: Control (no reminder)
Number of subjects: 1848
Study 18196610 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost per attendance for SMS
Number of subjects: 1848
Study 18196610 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost per attendance for telephone
Number of subjects: 1848
Study 16310902 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular revaccination (10 microg per dose)
Number of subjects: 40
Study 16310902 — intervention group
Group type: COMPARATOR
Intervention: Intradermal revaccination (2 microg per dose)
Number of subjects: 40
Study 16310902 — intervention group
Group type: EXPERIMENTAL
Intervention: Booster dose (5 microg) for those who lost seroprotection
Number of subjects: 40
Study 15115101 — intervention group
Group type: EXPERIMENTAL
Intervention: DTPa vaccine
Number of subjects: 180
Study 15115101 — intervention group
Group type: COMPARATOR
Intervention: DTPw vaccine
Number of subjects: 180
Study 10907947 — intervention group
Group type: COMPARATOR
Intervention: 5-fluorouracil (450 mg/m2 i.v. weekly) and levamisole (150 mg p.o. every two weeks)
Number of subjects: 500
Study 10907947 — intervention group
Group type: EXPERIMENTAL
Intervention: Leucovorin (20 mg/m2 i.v.), 5-fluorouracil and levamisole
Number of subjects: 500
Study 9362435 — intervention group
Group type: EXPERIMENTAL
Intervention: Clodronate, 300 mg/day intravenously (i.v.)
Number of subjects: 12
Study 9362435 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral clodronate, 1600-3200 mg/day
Number of subjects: 12
Study 9362435 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate, 5 mg i.v. as a single infusion
Number of subjects: 12
Study 9362435 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate, 40 mg orally/day
Number of subjects: 12
Study 9362435 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplements
Number of subjects: 12
Study 31340493 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (weight loss, healthy diet, physical activity)
Number of subjects: 211
Study 31340493 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 211
Study 29189306 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic exercise
Number of subjects: 136
Study 29189306 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive resisted exercise
Number of subjects: 136
Study 29189306 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 136
Study 27725911 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (IC) with docetaxel (DOC) plus nedaplatin (NDP) followed by IMRT concurrent with weekly NDP
Number of subjects: 223
Study 24694530 — intervention group
Group type: EXPERIMENTAL
Intervention: IV metoprolol
Number of subjects: 270
Study 24694530 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 270
Study 21926660 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 24
Study 21926660 — intervention group
Group type: COMPARATOR
Intervention: Spontaneously Breathing
Number of subjects: 24
Study 18379260 — intervention group
Group type: EXPERIMENTAL
Intervention: Various interventions studied in randomized controlled trials
Number of subjects: 72
Study 17063217 — intervention group
Group type: EXPERIMENTAL
Intervention: Mood disorders group
Number of subjects: 0
Study 17063217 — intervention group
Group type: EXPERIMENTAL
Intervention: Manic episode subgroup
Number of subjects: 0
Study 17063217 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 12947431 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 g of guar gum (3.6 g galactomannan)
Number of subjects: 30
Study 12947431 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 g of fructose
Number of subjects: 30
Study 12947431 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 g of guar gum + 5 g of fructose
Number of subjects: 30
Study 12947431 — intervention group
Group type: COMPARATOR
Intervention: Control (50 g of available carbohydrate from maltodextrin and white bread)
Number of subjects: 30
Study 11143452 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-talker sentence lists
Number of subjects: 0
Study 11143452 — intervention group
Group type: COMPARATOR
Intervention: Mixed-talker sentence lists
Number of subjects: 0
Study 11143452 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-color visual stimuli
Number of subjects: 0
Study 11143452 — intervention group
Group type: COMPARATOR
Intervention: Mixed-color visual stimuli
Number of subjects: 0
Study 9249631 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical metronidazole (95% collagen and 5% metronidazole device) combined with mechanical treatment
Number of subjects: 30
Study 9249631 — intervention group
Group type: COMPARATOR
Intervention: Mechanical treatment alone
Number of subjects: 30
Study 8309665 — intervention group
Group type: EXPERIMENTAL
Intervention: Amnioinfusion with room temperature normal saline (0.9%)
Number of subjects: 0
Study 8309665 — intervention group
Group type: COMPARATOR
Intervention: Amnioinfusion
Number of subjects: 0
Study 8309665 — intervention group
Group type: EXPERIMENTAL
Intervention: Transabdominal amnioinfusion
Number of subjects: 0
Study 3828955 — intervention group
Group type: EXPERIMENTAL
Intervention: L‐phenylalanine mustard (L‐PAM) and 5‐fluorouracil (5‐FU) with tamoxifen
Number of subjects: 1597
Study 3828955 — intervention group
Group type: COMPARATOR
Intervention: L‐phenylalanine mustard (L‐PAM) and 5‐fluorouracil (5‐FU) without tamoxifen
Number of subjects: 1597
Study 31509842 — intervention group
Group type: EXPERIMENTAL
Intervention: Heidelberg Spectralis II OCT-A with EA-Tool software
Number of subjects: 23
Study 28778405 — intervention group
Group type: COMPARATOR
Intervention: Permanent running lights on bicycles
Number of subjects: 6800
Study 28778405 — intervention group
Group type: COMPARATOR
Intervention: Yellow bicycle jacket
Number of subjects: 6800
Study 27510539 — intervention group
Group type: EXPERIMENTAL
Intervention: Gene-based personalized nutrition (PN)
Number of subjects: 1466
Study 27510539 — intervention group
Group type: COMPARATOR
Intervention: Nongene-based PN (level 2)
Number of subjects: 1466
Study 27510539 — intervention group
Group type: COMPARATOR
Intervention: Standard dietary advice (level 0)
Number of subjects: 1466
Study 27510539 — intervention group
Group type: EXPERIMENTAL
Intervention: APOE genotype E4+
Number of subjects: 1466
Study 26576815 — intervention group
Group type: EXPERIMENTAL
Intervention: Klar bleiben intervention (75 classes)
Number of subjects: 3000
Study 26576815 — intervention group
Group type: COMPARATOR
Intervention: Control group (75 classes)
Number of subjects: 3000
Study 23752849 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative ozone and postoperative millimeter wave therapy
Number of subjects: 0
Study 20801265 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual myoelectric hand
Number of subjects: 34
Study 20801265 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolated prosthetic hand
Number of subjects: 34
Study 20801265 — intervention group
Group type: EXPERIMENTAL
Intervention: Prosthetic simulator
Number of subjects: 34
Study 20801265 — intervention group
Group type: COMPARATOR
Intervention: All training types
Number of subjects: 34
Study 18752143 — intervention group
Group type: EXPERIMENTAL
Intervention: L‐NMMA
Number of subjects: 13
Study 18752143 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 16033924 — intervention group
Group type: EXPERIMENTAL
Intervention: Event-related functional magnetic resonance imaging (fMRI)
Number of subjects: 0
Study 12954574 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐fluorouracil [450 mg/m(2) intravenous (i.v.) bolus on days 1‐5] and levamisole (150 mg orally for 3 days, every 14 days for 6 months)
Number of subjects: 1703
Study 12954574 — intervention group
Group type: COMPARATOR
Intervention: 6‐S‐leucovorin (100 mg/m(2) i.v. bolus on days 1‐5) followed by 5‐fluorouracil (370 mg/m(2) i.v. bolus on days 1‐5), plus levamisole (as arm A), every 4 weeks for six cycles
Number of subjects: 1703
Study 15505964 — intervention group
Group type: EXPERIMENTAL
Intervention: Phonological awareness program
Number of subjects: 45
Study 15505964 — intervention group
Group type: EXPERIMENTAL
Intervention: Word analogy program
Number of subjects: 45
Study 15505964 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 45
Study 9375538 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting with supported forearms
Number of subjects: 0
Study 9375538 — intervention group
Group type: EXPERIMENTAL
Intervention: Using a mouse with supported forearms
Number of subjects: 0
Study 1347757 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin (20‐80 mg daily)
Number of subjects: 8245
Study 1347757 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8245
Study 1347757 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin
Number of subjects: 8245
Study 2863220 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (100 mg once a day)
Number of subjects: 21
Study 2863220 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine (10 mg three times a day)
Number of subjects: 21
Study 31811497 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy
Number of subjects: 70
Study 31811497 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen 600 mg
Number of subjects: 70
Study 30035578 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol targeting a blood alcohol concentration (BAC) of .08 g%
Number of subjects: 447
Study 30035578 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 447
Study 28760209 — intervention group
Group type: EXPERIMENTAL
Intervention: Insertable cardiac monitor (ICM) for continuous arrhythmia monitoring
Number of subjects: 500
Study 28760209 — intervention group
Group type: COMPARATOR
Intervention: Standard of care follow-up
Number of subjects: 500
Study 26206075 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention control training
Number of subjects: 0
Study 26206075 — intervention group
Group type: COMPARATOR
Intervention: Attention bias modification
Number of subjects: 0
Study 24018099 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentence production task with two objects and a verb, examining four types of disfluency: filled pauses, unfilled pauses, repetitions, and repairs.
Number of subjects: 106
Study 21153822 — intervention group
Group type: EXPERIMENTAL
Intervention: Zibotentan 10 mg plus pemetrexed 500 mg/m²
Number of subjects: 66
Study 21153822 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus pemetrexed 500 mg/m²
Number of subjects: 66
Study 21153822 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 66
Study 18297971 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium (2 grams)
Number of subjects: 104
Study 18297971 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 104
Study 16529781 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 degrees C thermal stimulus applied to the tongue
Number of subjects: 12
Study 16529781 — intervention group
Group type: EXPERIMENTAL
Intervention: 22 degrees C thermal stimulus applied to the tongue
Number of subjects: 12
Study 16529781 — intervention group
Group type: EXPERIMENTAL
Intervention: 44 degrees C thermal stimulus applied to the tongue
Number of subjects: 12
Study 16529781 — intervention group
Group type: EXPERIMENTAL
Intervention: Resting temperature of the tongue
Number of subjects: 12
Study 16529781 — intervention group
Group type: COMPARATOR
Intervention: Hypothenar of the hand (control site)
Number of subjects: 12
Study 12957333 — intervention group
Group type: EXPERIMENTAL
Intervention: Coaching by community pharmacists
Number of subjects: 0
Study 12957333 — intervention group
Group type: COMPARATOR
Intervention: Control group (no coaching)
Number of subjects: 0
Study 11030858 — intervention group
Group type: EXPERIMENTAL
Intervention: Resuscitation course with didactic lectures and skills practice stations, including a minimum of 3 practice mock resuscitations with immediate feedback throughout postgraduate year 3.
Number of subjects: 58
Study 9216977 — intervention group
Group type: EXPERIMENTAL
Intervention: PETCO2
Number of subjects: 12
Study 9216977 — intervention group
Group type: EXPERIMENTAL
Intervention: PJCO2
Number of subjects: 12
Study 8227863 — intervention group
Group type: EXPERIMENTAL
Intervention: Aqueous beclomethasone dipropionate (168 micrograms twice daily)
Number of subjects: 12
Study 8227863 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide (220 micrograms twice daily)
Number of subjects: 12
Study 8227863 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 12
Study 3524050 — intervention group
Group type: EXPERIMENTAL
Intervention: Live cold-adapted recombinant bivalent vaccine of influenza type A
Number of subjects: 30000
Study 3524050 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 30000
Study 30680521 — intervention group
Group type: EXPERIMENTAL
Intervention: Niraparib 300 mg once daily
Number of subjects: 58
Study 28148501 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril-folic acid (10 mg enalapril and 0.8 mg folic acid)
Number of subjects: 15364
Study 28148501 — intervention group
Group type: COMPARATOR
Intervention: Enalapril alone (10 mg enalapril)
Number of subjects: 15364
Study 26254941 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Regulation Treatment Group (n = 136)
Number of subjects: 274
Study 26254941 — intervention group
Group type: COMPARATOR
Intervention: Self-Efficacy Treatment Group (n = 138)
Number of subjects: 274
Study 23472068 — intervention group
Group type: EXPERIMENTAL
Intervention: Market priming using phrases related to markets and trade
Number of subjects: 0
Study 23472068 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified how they were treated)
Number of subjects: 0
Study 21088912 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day recall questionnaire
Number of subjects: 140
Study 21088912 — intervention group
Group type: COMPARATOR
Intervention: Daily diary for 7 days
Number of subjects: 140
Study 19719710 — intervention group
Group type: EXPERIMENTAL
Intervention: Custom foot orthoses
Number of subjects: 61
Study 19719710 — intervention group
Group type: COMPARATOR
Intervention: Sham insoles
Number of subjects: 61
Study 19719710 — intervention group
Group type: EXPERIMENTAL
Intervention: Custom foot orthoses and Sham insoles
Number of subjects: 61
Study 17244518 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone 50mg
Number of subjects: 151
Study 17244518 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151
Study 15531696 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg Ca/d
Number of subjects: 113
Study 15531696 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 113
Study 11379850 — intervention group
Group type: EXPERIMENTAL
Intervention: BPRS-A (Brief Psychiatric Rating Scale-Anchored)
Number of subjects: 207
Study 9757152 — intervention group
Group type: EXPERIMENTAL
Intervention: Grapefruit juice
Number of subjects: 10
Study 9757152 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 10
Study 8154971 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose intravenous ganciclovir for 3 weeks (group 2, n = 24)
Number of subjects: 51
Study 8154971 — intervention group
Group type: EXPERIMENTAL
Intervention: Seven doses of intravenous immunoglobulin for 6-week periods (group 1, n = 27)
Number of subjects: 51
Study 8154971 — intervention group
Group type: COMPARATOR
Intervention: Historical controls who received renal allografts from CMV-seropositive donors between 1987 and 1989 (group 3, n = 23)
Number of subjects: 51
Study 3042356 — intervention group
Group type: EXPERIMENTAL
Intervention: urapidil (60 to 120 mg/day)
Number of subjects: 44
Study 3042356 — intervention group
Group type: COMPARATOR
Intervention: atenolol (50 to 100 mg/day)
Number of subjects: 44
Study 3042356 — intervention group
Group type: EXPERIMENTAL
Intervention: urapidil
Number of subjects: 44
Study 3042356 — intervention group
Group type: COMPARATOR
Intervention: atenolol
Number of subjects: 44
Study 29489876 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic yoghurt
Number of subjects: 14
Study 29489876 — intervention group
Group type: COMPARATOR
Intervention: Acidified milk
Number of subjects: 14
Study 28173897 — intervention group
Group type: EXPERIMENTAL
Intervention: IMB-based pilot intervention
Number of subjects: 68
Study 28173897 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 68
Study 26298795 — intervention group
Group type: EXPERIMENTAL
Intervention: Nightly dosing with 10 mg zolpidem (QHS-10)
Number of subjects: 74
Study 26298795 — intervention group
Group type: EXPERIMENTAL
Intervention: Nightly dosing with 5 mg zolpidem (QHS-5)
Number of subjects: 74
Study 26298795 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent dosing with 10 mg zolpidem (IDS-10)
Number of subjects: 74
Study 26298795 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial reinforcement dosing with 10 mg zolpidem (PRS-10)
Number of subjects: 74
Study 23246610 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment indicated for schizophrenia (specific treatments not detailed in the abstract)
Number of subjects: 18239
Study 23246610 — intervention group
Group type: EXPERIMENTAL
Intervention: Recruitment strategies implemented in ZODIAC study
Number of subjects: 18239
Study 21696871 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric contractions at 30%, 40%, 50%, and 60% of maximum voluntary contraction
Number of subjects: 20
Study 18420167 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional dyspepsia (FD) in women
Number of subjects: 176
Study 18420167 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional dyspepsia (FD) in men
Number of subjects: 176
Study 16930215 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol at 0.1% BAL
Number of subjects: 0
Study 16930215 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol at 0.03% BAL
Number of subjects: 0
Study 16930215 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-discontinuation of alcohol at 0.1% BAL
Number of subjects: 0
Study 16930215 — intervention group
Group type: EXPERIMENTAL
Intervention: Withdrawal from alcohol at 0.1% BAL
Number of subjects: 0
Study 12966595 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferrous sulfate 300 mg twice daily
Number of subjects: 10
Study 12966595 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 10894865 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin/vincristine/fluorouracil (regimen A)
Number of subjects: 182